The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial.
about
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BIn vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysisBiological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaquesA randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.Review of hepatitis B therapeutics.Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis BAssessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B: A meta-analysisAgents in clinical development for the treatment of chronic hepatitis B.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Adefovir nephrotoxicity in a renal allograft recipientSevere metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir.Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.Adefovir dipivoxil in chronic hepatitis B infection.4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfectionCurrent treatment of HIV/hepatitis B virus coinfection.Experience with tenofovir disoproxil fumarate for antiretroviral therapy.Drug safety evaluation of adefovir in HBV infection.Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.Adefovir dipivoxil in chronic hepatitis B: history and current uses.Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition.Antimicrobial-induced Electrolyte and Acid-Base Disturbances.Hepatitis B virus infection in children.DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients.Adefovir-induced Fanconi syndrome: diagnostic pearls and perils of late or missed diagnosis.Tenofovir nephrotoxicity: 2011 update.Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
P2860
Q27030828-2F002099-A41E-4431-993C-259880B1745BQ28486262-C9FE59F7-E193-47C2-AB63-451C0CB881C7Q28775900-A53913A5-3CD1-4395-A1C5-142C9139556AQ33962669-C75DB85E-3412-4CC2-8423-69A7A6155DB0Q34296410-74C4AB9B-E6D1-497F-9126-6B37888CF53DQ35078052-AE8BE7B6-7D64-4D18-8B82-1739CCB61EABQ35155913-8AA7C96F-BC73-441F-8B7E-9C76041DFA5DQ35180009-9EF3A38B-AF00-48D3-8FCB-1FBE566704CBQ35185749-4E3A7438-BF48-4754-8B7F-1966F95C2D9EQ35558801-DA68DF8E-942F-436F-863B-1F77BF70C268Q35658786-9090B1D2-7D95-4DD2-9266-78596BFA00B8Q35852636-6B8A0353-CCC2-411D-981E-423C7468477BQ35917125-FED0AF40-1FEA-43ED-91A7-F6836CD1F777Q35925551-EDB4BBD7-E0D1-489A-B2BF-CD38540B12A7Q36108952-DEA40096-1B1E-49CB-9FB3-EB1C953BA7E2Q36342389-0338A19F-FD46-4558-8EDA-9E7DE6C43475Q36407276-EFD5773A-0328-41DD-A5F4-19697D1AAA4EQ36982099-E6B96BB8-8783-42F6-A866-0B46EC61B3E5Q37138048-DDA0696A-E87C-43CE-8714-B7AB1806A321Q37142078-EAE1AE88-B923-4B7E-860B-3792FFBC0505Q37889298-A6725F3D-727C-4A0A-A40F-30EE8A445DC6Q37974690-08F29174-8D67-4342-AE71-B4708CB33D1EQ37975548-957ABFA5-E6FF-4C52-849C-4C0F0A00D8F8Q38099411-50B654FC-1080-42D0-B521-78898FF41371Q38181479-10DBE53D-0025-4FF5-91FE-41A70DCC7A24Q38365905-B98D9617-74AE-4256-806C-C3B42E55D3ECQ38692333-ADF874B5-54AF-405A-B3AE-2F4FE87821B9Q38839020-29CD3593-E026-4FFD-ACE8-B1649C889062Q42123423-BAE86F7C-53D0-4261-A754-9CEE0FA60AD5Q42254390-FDC76436-FA87-4928-8C42-E927156AC8C4Q43607727-E40D72D3-9C43-4EEE-97B7-FCDEF266BD65Q44396659-7EC5A4A3-6C87-4C23-9793-C47E78532A3EQ44704148-73862FCB-1628-43FA-B3E9-F6BF284F2FF3Q46899237-4AA84EF8-D726-44DA-8C30-5967112DAD0B
P2860
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@ast
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@en
type
label
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@ast
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@en
prefLabel
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@ast
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@en
P2093
P1433
P1476
The safety and efficacy of ade ...... zed, placebo-controlled trial.
@en
P2093
B Schmetter
C L Brosgart
E J Fisher
K Chaloner
Terry Beirn Community Programs for Clinical Research on AIDS
W M El-Sadr
P304
P356
10.1097/00002030-200109070-00013
P407
P577
2001-09-01T00:00:00Z